These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
472 related items for PubMed ID: 7506680
1. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives. Nielsen CH, Poulsen HK, Teisner B, Thorsen P, Hau J, Westergaard JG. Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680 [Abstract] [Full Text] [Related]
2. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K. Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580 [Abstract] [Full Text] [Related]
7. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Akerlund M, Almström E, Högstedt S, Nabrink M. Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352 [Abstract] [Full Text] [Related]
8. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Hammond GL, Langley MS, Robinson PA, Nummi S, Lund L. Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179 [Abstract] [Full Text] [Related]
9. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Gaspard UJ, Buret J, Gillain D, Romus MA, Lambotte R. Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546 [Abstract] [Full Text] [Related]
16. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives. Norris LA, Bonnar J. Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312 [Abstract] [Full Text] [Related]
17. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum. Kuhnz W, Staks T, Jütting G. Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098 [Abstract] [Full Text] [Related]
19. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris. Mango D, Ricci S, Manna P, Miggiano GA, Serra GB. Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881 [Abstract] [Full Text] [Related]
20. Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives. Anderson FD. Acta Obstet Gynecol Scand Suppl; 1992 Mar; 156():15-21. PubMed ID: 1324552 [Abstract] [Full Text] [Related] Page: [Next] [New Search]